tiprankstipranks

Mark Robert Tobin Insider Profile

4 Followers
Mark Robert Tobin, Director at Innovation Pharmaceuticals, holds ― shares in Innovation Pharmaceuticals (Ticker: IPIX), holds 18.27K shares in Lightbridge (Ticker: LTBR). Most recently, Mark Robert Tobin ― shares of Innovation Pharmaceuticals on ― for an estimated value of ―.
tipranks
Mark Robert Tobin

Mark Robert Tobin
Innovation Pharmaceuticals (IPIX)
Director

Not Ranked
Mark Robert Tobin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$124K
100.00%
0.00%
A breakdown of Mark Robert Tobin's holdings

Insider Roles

Lightbridge
(LTBR)
Director
Innovation Pharmaceuticals
(IPIX)
Director
Roles that Mark Robert Tobin holds in companies

Most Profitable Insider Trade

Stock:
Lightbridge
(LTBR)
Rating:Informative Sell
Date:Mar 29, 2022 - Mar 29, 2023
Return:+55.80%
The most profitable trade made by Mark Robert Tobin

Mark Robert Tobin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Innovation Pharmaceuticals
Director
Lightbridge
Nov 22, 2024
Director
Informative Sell
25.88K
$124.40K
List of latest transactions for each holding click on a transaction to see Mark Robert Tobin's performance on stock

Mark Robert Tobin insider profile FAQ

What is the percentage of profitable transactions made by Mark Robert Tobin?
The percentage of profitable transactions made by Mark Robert Tobin is ―.
    What is the average return per transaction made by Mark Robert Tobin?
    The average return per transaction made by Mark Robert Tobin is ―.
      What stocks does Mark Robert Tobin hold?
      Mark Robert Tobin holds: IPIX, LTBR stocks.
        What was Mark Robert Tobin’s latest transaction?
        Mark Robert Tobin latest transaction was an Uninformative Buy of ―.
          What was Mark Robert Tobin's most profitable transaction?
          Mark Robert Tobin’s most profitable transaction was an Informative Sell of LTBR stock on March 29, 2022. The return on the trade was 55.80%.
            What is Mark Robert Tobin's role in Innovation Pharmaceuticals?
            Mark Robert Tobin's role in Innovation Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.